Skip to main content

Sacituzumab Govitecan-hziy

(SAK-ih-TOO-zoo-mab GOH-vih-TEE-kan)

This page contains brief information about sacituzumab govitecan-hziy and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Trodelvy
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Sacituzumab govitecan-hziy is approved to treat:

This use is approved under FDA’s Accelerated Approval Program. As a condition of approval, confirmatory trial(s) must show that sacituzumab govitecan-hziy provides a clinical benefit in these patients.

Sacituzumab govitecan-hziy is also being studied in the treatment of other types of cancer.

More About Sacituzumab Govitecan-hziy

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Monoclonal Antibodies

Clinical Trials Accepting Patients

Find Clinical Trials for Sacituzumab Govitecan-hziy - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: